According to a new joint analysis by CARE and Booz Allen Hamilton, the U.S. faces a choice: Invest at least $11.3 billion over the next three years to ensure vaccines reach the most vulnerable and hard-to-reach communities worldwide, particularly low-to-middle-income countries, or pay as much as almost $700 billion in continued economic loss if we fail to meet this global challenge.